Deep Yellow (ASX: DYL) is hitting pause on full-scale construction of its flagship Tumas Project in Namibia, deferring a final investment decision (FID) until uranium prices show more robust, long-term…
Nuix Eyes Lower End of FY25 ACV Growth Amid Global Uncertainty
Investigative analytics software firm Nuix (ASX: NXL) has flagged a more cautious outlook for the full year, with Annualised Contract Value (ACV) growth now expected to come in at the…
Capricorn Metals Delivers 31koz Gold in Q3, Ramping Up Toward FY25 Guidance
Capricorn Metals (ASX: CMM) has posted another solid performance at its Karlawinda Gold Project (KGP), producing 30,599 ounces of gold in the March quarter. That’s up from 28,702oz in the…
Takeover Talk: Abacus Storage King Gets a $1.47 Per Security Indicative Offer from Ki and Public Storage
Abacus Storage King (ASX: ASK) has confirmed it’s received a non-binding, conditional takeover proposal from a consortium led by Ki Corporation and U.S.-based storage giant Public Storage (NYSE: PSA). The…
Orthocell Scores Landmark FDA Clearance for Remplir, Opening Doors to US$1.6B Nerve Repair Market
4 April 2025 – Big moment for Perth-based Orthocell (ASX: OCC)—the company has landed 510(k) clearance from the U.S. FDA for its flagship nerve repair device, Remplir™, unlocking access to…
Mesoblast Confirms U.S. Country of Origin Status, Avoids Tariff Impact on Cell Therapy Products
4 April 2025 – Mesoblast (ASX: MSB; Nasdaq: MESO) has confirmed that its lead allogeneic cell therapy products, including Ryoncil® and Revascor®, are designated as U.S. origin products and will…
Bellevue Gold Remains in Suspension Amid March Quarter Production Challenges
Bellevue Gold (ASX: BGL) has confirmed its shares will remain in voluntary suspension, as the company is not yet ready to release its anticipated Updated Production Guidance Announcement. This follows…
Race Oncology Opens First Australian Clinical Site for RC220 Phase 1 Solid Tumour Trial
Race Oncology (ASX: RAC) has reached a key milestone, with the Southside Cancer Care Centre in Miranda, NSW, now activated for patient enrolment in its Phase 1 clinical trial of…
Cann Group Secures Supply Agreements with Chemist Warehouse in Queensland
Cann Group (ASX: CAN) has taken a major step forward in expanding access to its Botanitech range of medicinal cannabis products, signing supply agreements with 11 Chemist Warehouse outlets in…
Echo IQ Secures Mayo Clinic Collaboration, Advances FDA Approval for AI Heart Failure Detection
AI-driven medtech company Echo IQ (ASX: EIQ) has taken a major step forward in bringing its heart failure clinical decision support solution, EchoSolv HF, to market. The company has secured…